FDA Approved: ORILISSA — Original Application (AbbVie Inc.)

View source ↗

Summary

FDA approved Orilissa (elagolix) from AbbVie under NDA210450, marking the original approval of the therapy. It is indicated for the management of moderate to se…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Orilissa (elagolix)

Snippet

ORIG AP for ORILISSA (ELAGOLIX)